Related Experiment Video
Updated: Feb 7, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
A Novel Heterozygous Intronic Mutation in the FBN1 Gene Contributes to FBN1 RNA Missplicing Events in the Marfan
Mario Torrado1, Emilia Maneiro2, Juan Pablo Trujillo-Quintero2
1Institute of Health Sciences, University of A Coruña, A Coruña, Spain.
Abstract:
Marfan syndrome (MFS) is an autosomal dominantly inherited connective tissue disorder, mostly caused by mutations in the fibrillin-1 (FBN1) gene. We, by using targeted next-generation sequence analysis, identified a novel intronic FBN1 mutation (the c.2678-15C>A variant) in a MFS patient with aortic dilatation. The computational predictions showed that the heterozygous c.2678-15C>A intronic variant might influence the splicing process by differentially affecting canonical versus cryptic splice site utilization within intron 22 of the FBN1 gene. RT-PCR and Western blot analyses, using FBN1 minigenes transfected into HeLa and COS-7 cells, revealed that the c.2678-15C>A variant disrupts normal splicing of intron 22 leading to aberrant 13-nt intron 22 inclusion, frameshift, and premature termination codon. Collectively, the results strongly suggest that the c.2678-15C>A variant could lead to haploinsufficiency of the FBN1 functional protein and structural connective tissue fragility in MFS complicated by aorta dilation, a finding that further expands on the genetic basis of aortic pathology.
Insights
A novel intronic mutation in the FBN1 gene was identified in Marfan syndrome patients. This FBN1 mutation disrupts gene splicing, leading to connective tissue fragility and aortic dilation.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Disease
Background:
- Marfan syndrome (MFS) is an inherited connective tissue disorder.
- Mutations in the fibrillin-1 (FBN1) gene are the primary cause of MFS.
- Aortic dilatation is a serious complication of MFS.
Observation:
- A novel intronic FBN1 mutation (c.2678-15C>A) was identified in an MFS patient with aortic dilatation.
- Computational predictions suggested the variant affects FBN1 gene splicing.
- Experimental analyses confirmed aberrant splicing due to the variant.
Findings:
- The c.2678-15C>A variant causes abnormal inclusion of intron 22 in FBN1 mRNA.
- This leads to a frameshift and a premature termination codon.
- The variant results in FBN1 protein haploinsufficiency.
Implications:
- This finding expands the understanding of the genetic basis of MFS.
- It highlights the role of intronic mutations in FBN1-related disorders.
- This discovery may aid in diagnosing and managing MFS patients with aortic complications.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Organization of Genes
Mutations
Viral Mutations

